168 related articles for article (PubMed ID: 21242965)
1. hTID-1 defines a novel regulator of c-Met Receptor signaling in renal cell carcinomas.
Copeland E; Balgobin S; Lee CM; Rozakis-Adcock M
Oncogene; 2011 May; 30(19):2252-63. PubMed ID: 21242965
[TBL] [Abstract][Full Text] [Related]
2. hTid-1, a human DnaJ protein, modulates the interferon signaling pathway.
Sarkar S; Pollack BP; Lin KT; Kotenko SV; Cook JR; Lewis A; Pestka S
J Biol Chem; 2001 Dec; 276(52):49034-42. PubMed ID: 11679576
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas.
Looyenga BD; Furge KA; Dykema KJ; Koeman J; Swiatek PJ; Giordano TJ; West AB; Resau JH; Teh BT; MacKeigan JP
Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1439-44. PubMed ID: 21220347
[TBL] [Abstract][Full Text] [Related]
4. Human T cell leukemia virus type 1 Tax associates with a molecular chaperone complex containing hTid-1 and Hsp70.
Cheng H; Cenciarelli C; Shao Z; Vidal M; Parks WP; Pagano M; Cheng-Mayer C
Curr Biol; 2001 Nov; 11(22):1771-5. PubMed ID: 11719219
[TBL] [Abstract][Full Text] [Related]
5. Absence of a human DnaJ protein hTid-1S correlates with aberrant actin cytoskeleton organization in lesional psoriatic skin.
Choi JH; Choi DK; Sohn KC; Kwak SS; Suk J; Lim JS; Shin I; Kim SW; Lee JH; Joe CO
J Biol Chem; 2012 Jul; 287(31):25954-63. PubMed ID: 22692211
[TBL] [Abstract][Full Text] [Related]
6. The mitochondrial protein hTID-1 partners with the caspase-cleaved adenomatous polyposis cell tumor suppressor to facilitate apoptosis.
Qian J; Perchiniak EM; Sun K; Groden J
Gastroenterology; 2010 Apr; 138(4):1418-28. PubMed ID: 19900451
[TBL] [Abstract][Full Text] [Related]
7. Novel roles of c-Met in the survival of renal cancer cells through the regulation of HO-1 and PD-L1 expression.
Balan M; Mier y Teran E; Waaga-Gasser AM; Gasser M; Choueiri TK; Freeman G; Pal S
J Biol Chem; 2015 Mar; 290(13):8110-20. PubMed ID: 25645920
[TBL] [Abstract][Full Text] [Related]
8. Increase in hepatocyte growth factor receptor tyrosine kinase activity in renal carcinoma cells is associated with increased motility partly through phosphoinositide 3-kinase activation.
Nakamura T; Kanda S; Yamamoto K; Kohno T; Maeda K; Matsuyama T; Kanetake H
Oncogene; 2001 Nov; 20(52):7610-23. PubMed ID: 11753639
[TBL] [Abstract][Full Text] [Related]
9. Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling.
Wang M; Sun Y; Xu J; Lu J; Wang K; Yang DR; Yang G; Li G; Chang C
Int J Cancer; 2018 Jul; 143(1):100-112. PubMed ID: 29396852
[TBL] [Abstract][Full Text] [Related]
10. Targeting the hepatocyte growth factor/c-Met signaling pathway in renal cell carcinoma.
Harshman LC; Choueiri TK
Cancer J; 2013; 19(4):316-23. PubMed ID: 23867513
[TBL] [Abstract][Full Text] [Related]
11. Radiation stimulates HGF receptor/c-Met expression that leads to amplifying cellular response to HGF stimulation via upregulated receptor tyrosine phosphorylation and MAP kinase activity in pancreatic cancer cells.
Qian LW; Mizumoto K; Inadome N; Nagai E; Sato N; Matsumoto K; Nakamura T; Tanaka M
Int J Cancer; 2003 May; 104(5):542-9. PubMed ID: 12594808
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.
Maulik G; Kijima T; Ma PC; Ghosh SK; Lin J; Shapiro GI; Schaefer E; Tibaldi E; Johnson BE; Salgia R
Clin Cancer Res; 2002 Feb; 8(2):620-7. PubMed ID: 11839685
[TBL] [Abstract][Full Text] [Related]
13. Presence of phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor progression and survival in patients with conventional renal cell carcinoma.
Miyata Y; Kanetake H; Kanda S
Clin Cancer Res; 2006 Aug; 12(16):4876-81. PubMed ID: 16914575
[TBL] [Abstract][Full Text] [Related]
14. TID1, a human homolog of the Drosophila tumor suppressor l(2)tid, encodes two mitochondrial modulators of apoptosis with opposing functions.
Syken J; De-Medina T; Münger K
Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8499-504. PubMed ID: 10411904
[TBL] [Abstract][Full Text] [Related]
15. Progression of colorectal cancers correlates with overexpression and loss of polarization of expression of the htid-1 tumor suppressor.
Kurzik-Dumke U; Hörner M; Czaja J; Nicotra MR; Simiantonaki N; Koslowski M; Natali PG
Int J Mol Med; 2008 Jan; 21(1):19-31. PubMed ID: 18097612
[TBL] [Abstract][Full Text] [Related]
16. Putting human Tid-1 in context: an insight into its role in the cell and in different disease states.
Banerjee S; Chaturvedi R; Singh A; Kushwaha HR
Cell Commun Signal; 2022 Jul; 20(1):109. PubMed ID: 35854300
[TBL] [Abstract][Full Text] [Related]
17. Piperlongumine and its analogs down-regulate expression of c-Met in renal cell carcinoma.
Golovine K; Makhov P; Naito S; Raiyani H; Tomaszewski J; Mehrazin R; Tulin A; Kutikov A; Uzzo RG; Kolenko VM
Cancer Biol Ther; 2015; 16(5):743-9. PubMed ID: 25801713
[TBL] [Abstract][Full Text] [Related]
18. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.
Comoglio PM
EXS; 1993; 65():131-65. PubMed ID: 8380735
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of the met/HGF receptor in renal cell carcinomas.
Natali PG; Prat M; Nicotra MR; Bigotti A; Olivero M; Comoglio PM; Di Renzo MF
Int J Cancer; 1996 Jun; 69(3):212-7. PubMed ID: 8682590
[TBL] [Abstract][Full Text] [Related]
20. c-Src kinase activity is required for hepatocyte growth factor-induced motility and anchorage-independent growth of mammary carcinoma cells.
Rahimi N; Hung W; Tremblay E; Saulnier R; Elliott B
J Biol Chem; 1998 Dec; 273(50):33714-21. PubMed ID: 9837958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
